If COVID-19 Is a Respiratory Disease, Why Are We Not Addressing It In The Nose?

Articles
A  Pathophysiological Perspective on COVID-19’s Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.

 Infection Chemotherapy. Sep 2020. doi: 10.3947/ic.2020.52.3.335. Epub 2020 Jul 15.  – Marcos A Sanchez-Gonzalez, Dave Moskowitz, Priya D Issuree, George Yatzkan, Syed A A Rizvi, Kenneth Day 

Intranasal Antiviral Drug Delivery and Coronavirus Disease (COVID-19):
A State-of-the-Art Review.

Otolaryngol - Head and Neck Surgery. July 14, 2020. doi: 10.1177/0194599820933170. Online ahead of print.  – Thomas S. Higgins, MD, MSPH, Arthur W. Wu, MD, Elisa A Illing, et. al. 

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. 

New England Journal of Medicine. Mar 19, 2020.  – Lirong Zou, M.Sc., Feng Ruan, M.Med., Mingxing Huang, Ph.D., et. al. 

Healthy Living Magazine 3 Stages of COVID-19
Information You Should Know about COVID-19